Cargando…
Development of stem cell-based therapy for Parkinson’s disease
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders of aging, characterized by the degeneration of dopamine neurons (DA neurons) in the substantial nigra, leading to the advent of both motor symptoms and non-motor symptoms. Current treatments include electrical stimulation...
Autores principales: | Han, Fabin, Baremberg, Deborah, Gao, Junyu, Duan, Jing, Lu, Xianjie, Zhang, Nan, Chen, Qingfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559356/ https://www.ncbi.nlm.nih.gov/pubmed/26339485 http://dx.doi.org/10.1186/s40035-015-0039-8 |
Ejemplares similares
-
Epigenetic modification in Parkinson’s disease
por: Song, Hao, et al.
Publicado: (2023) -
Possible role of EphA4 and VEGFR2 interactions in neural stem and progenitor cell differentiation
por: Chen, Qingfa, et al.
Publicado: (2020) -
Stem Cell-Based Therapies for Parkinson Disease
por: Liu, Zhaohui, et al.
Publicado: (2020) -
The Interaction of EphA4 With PDGFRβ Regulates Proliferation and Neuronal Differentiation of Neural Progenitor Cells in vitro and Promotes Neurogenesis in vivo
por: Chen, Qingfa, et al.
Publicado: (2020) -
Stem cell therapy for Parkinson's disease
por: Björklund, Lars M.
Publicado: (2004)